We are live on ! Find out more
SC

Sophrosyne Capital Portfolio holdings

AUM $11.5M
1-Year Est. Return 17.82%
This Fund
S&P 500
This Quarter Est. Return
-1.41%
1 Year Est. Return
+17.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$84.7M
AUM Growth
-$13.5M
Cap. Flow
-$7.95M
Cap. Flow %
-9.38%
Top 10 Hldgs %
56.12%
Holding
79
New
15
Increased
14
Reduced
18
Closed
21

Top Buys

Rank Stock Value
1
IRMD icon
iRadimed
IRMD
+$3.43M
2
CYNO
Cynosure, Inc. Class A
CYNO
+$1.47M
3
LPSN icon
LivePerson
LPSN
+$1.37M
4
PCYO icon
Pure Cycle
PCYO
+$1.12M
5
SILC icon
Silicom
SILC
+$1.03M

Top Sells

Rank Stock Value
1
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$2.95M
2
ARCT icon
Arcturus Therapeutics
ARCT
+$2.68M
3
BKNG icon
Booking.com
BKNG
+$1.68M
4
FLNA
Filana Therapeutics
FLNA
+$1.6M
5
CPRX
Catalyst Pharmaceutical
CPRX
+$1.52M

Sector Composition

Rank Sector Weight
1 Healthcare 44.42%
2 Technology 19.14%
3 Utilities 9.4%
4 Financials 8.41%
5 Communication Services 7.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZLTQ
1
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$8.7M 10.26%
384,418
-44,286
-10% -$877K
BEAT
2
DELISTED
BioTelemetry, Inc.
BEAT
$7.56M 8.92%
1,126,974
-29,000
-3% -$203K
MSTR icon
3
Strategy Inc
MSTR
$54.6B
$5.86M 6.91%
447,500
-62,500
-12% -$869K
BFYT
4
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$5.61M 6.62%
519,870
-39,000
-7% -$487K
PCYO icon
5
Pure Cycle
PCYO
$275M
$5.28M 6.23%
816,148
+170,148
+26% +$1.12M
MEET
6
DELISTED
The Meet Group, Inc. Common Stock
MEET
$3.47M 4.1%
1,762,827
+100,000
+6% +$227K
BDSI
7
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$3.28M 3.88%
192,176
-203,100
-51% -$2.95M
CDZI icon
8
Cadiz
CDZI
$334M
$2.68M 3.17%
258,279
+52,800
+26% +$542K
IRMD icon
9
iRadimed
IRMD
$1.11B
$2.65M 3.13%
+378,771
New +$3.43M
ARCT icon
10
Arcturus Therapeutics
ARCT
$460M
$2.47M 2.91%
22,832
-20,536
-47% -$2.68M
RTK
11
DELISTED
Rentech, Inc.
RTK
$2.38M 2.81%
139,520
+37,922
+37% +$824K
PKT
12
DELISTED
PROCERA NETWORKS INC NEW COM STK (DE)
PKT
$2.31M 2.73%
240,906
-41,184
-15% -$410K
FLNA
13
Filana Therapeutics
FLNA
$44.6M
$2.27M 2.68%
83,109
-52,800
-39% -$1.6M
CSII
14
DELISTED
Cardiovascular Systems, Inc.
CSII
$2.17M 2.56%
91,841
-1,100
-1% -$31.3K
DRRX
15
DELISTED
DURECT Corp
DRRX
$1.77M 2.08%
120,211
-6,691
-5% -$104K
SRL icon
16
Scully Royalty
SRL
$88.9M
$1.52M 1.79%
42,700
+14,680
+52% +$562K
SHOR
17
DELISTED
ShoreTel, Inc.
SHOR
$1.49M 1.76%
224,560
+1,000
+0.4% +$6.47K
LPSN icon
18
LivePerson
LPSN
$34.4M
$1.45M 1.71%
+7,700
New +$1.37M
CYNO
19
DELISTED
Cynosure, Inc. Class A
CYNO
$1.41M 1.66%
+67,000
New +$1.47M
SILC icon
20
Silicom
SILC
$274M
$1.4M 1.66%
48,100
+33,100
+221% +$1.03M
ENT
21
DELISTED
Global Eagle Entertainment Inc.
ENT
$1.35M 1.6%
4,832
+1,160
+32% +$337K
AXGN icon
22
Axogen
AXGN
$2.78B
$1.34M 1.59%
550,607
– –
KFX
23
DELISTED
KOFAX LIMITED COM STK
KFX
$1.24M 1.46%
160,400
+25,500
+19% +$196K
UI icon
24
Ubiquiti
UI
$35.9B
$1.19M 1.4%
31,713
-20,150
-39% -$856K
AVAV icon
25
AeroVironment
AVAV
$7.74B
$1.15M 1.35%
38,100
+6,700
+21% +$213K
1
2 3 4

Similar funds

SFM
Socratic Fund Management Short Hills, New Jersey $12M AUM 39.3% 1-Year Est. Return
IACGFA
IDG-Accel China Growth Fund Associates Central, Hong Kong $13.2M AUM 31.6% 1-Year Est. Return
LS
Lupo Securities Chicago, Illinois $13.3M AUM 1.59% 1-Year Est. Return
NGPI
N.G. Partners II Palo Alto, California $9.65M AUM 70.44% 1-Year Est. Return
AP
AGTC Partners Cambridge, Massachusetts $13.6M AUM 15.62% 1-Year Est. Return
GRP
Geologic Resource Partners Boston, Massachusetts $9.22M AUM 48.14% 1-Year Est. Return
NVPV
Norwest Venture Partners VIII Palo Alto, California $9.22M AUM
AC
Amiya Capital London, United Kingdom $14.3M AUM 4.61% 1-Year Est. Return

Sophrosyne Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Sophrosyne Capital held 79 positions worth $84.7M, down 14% from $98.2M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Sophrosyne Capital withdrew a net $7.95M in Q3 2014, closing 21 positions and reducing 18 holdings. Its most notable exit was Booking.com, an estimated $1.68M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 45% a quarter earlier, followed by Technology and Utilities.

Against the trend, Sophrosyne Capital opened a new position in iRadimed worth $2.65M.

  • Sophrosyne Capital's largest Q3 2014 buy was iRadimed: 378,771 shares worth $2.65M.
  • Sophrosyne Capital added most to Pure Cycle in Q3 2014, an estimated $1.12M increase.
  • Sophrosyne Capital's biggest Q3 2014 reduction was BioDelivery Sciences International, Inc., cutting an estimated $2.95M.
  • Sophrosyne Capital fully exited Booking.com in Q3 2014, selling an estimated $1.68M.
  • Sophrosyne Capital's ten largest holdings make up 56% of its $84.7M portfolio in Q3 2014.
  • Sophrosyne Capital opened 15 new positions and closed 21 in Q3 2014.
  • Sophrosyne Capital's portfolio value fell 14% quarter-over-quarter to $84.7M.

Based on Sophrosyne Capital's 13F filing for Q3 2014, filed 14 Nov 2014.